Sunday, July 20, 2014 1:39:08 PM
The origination of the claimed $200K(that in disclosures was never mentioned that wasn't settled)is what I see Aaron basing his case on and after reading some older DISCLOSURES I know what Aaron means in his statement.
Maybe Aaron found out that the $200K in question as claimed by Matt was/is a lie according to DISCLOSURES because $200K isn't mentioned in DISCLOSURES by Matt's puppet, Randy Schneider.
What was DISCLOSED was $150K and no information about the origination of that "note" as all other notes had been settled through what all these share selling schemes use, shares. It just showed up all of a sudden with no information about it.
In any lawsuit like this, a big factor would be the origination of the debt and is key as to whether it will hold up in court as a legal debt and in this case the debt looks very suspicious because it just magically shows up all of a sudden in the end of the year for 2011, just before the "huge news" announced by Randy on 12/5/2011, the same day Aaron created BGMT, which last time I looked was REVOKED by Nevada for lack of the annual FILING with the Secretary of State in Florida and is for $150K, not $200K.
BTW, the difference between a FILING and a DISCLOSURE is that in a FILING if the signer is lying about anything there are legal ramifications and possible criminal charges can be brought against the signer. A DISCLOSURE has no legal ramifications for lying and lie they do, over and over.
Here's a prime example, in DISCLOSURES while Matt's brother Joseph was here part of the DISCLOSURE says:
All 3 are lies when real investors read things for themselves instead of reading and believing the promotional PRs and the "DD" that always follows and is based on that PR.
The same writing is in Randy's DISCLOSURE but come on, one or more of Randy's "companies" are "acquired" by RIGH and it isn't listed as a "related Party Transaction" or a "Conflict of Interest?"
RIGH has been a Matt Dwyer share selling scheme for years and has been given billions of shares for him to sell.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM